MentionFox
Home › funding signals › Halia Therapeutics, Inc.
Company · SEC filings

Halia Therapeutics, Inc. funding history

Halia Therapeutics, Inc. has 3 Form D filings on record, from 2022-12-30 to 2026-08-31. Together its new offerings report $15.71M sold.

Funding historyFounders and team

What do you want to do with Halia Therapeutics, Inc.?

Based
Lehi, UTAH
Industry group
Biotechnology
Filings
3
Raised (new offerings)
$15.71M

Every filing

FiledTypeAmount soldTotal offeringRecords
2026-08-31New offering
first sale 2026-08-17
$3.49M$20MSEC filing
2025-07-16Filing——SEC filing
2022-12-30New offering
first sale 2022-12-16
$12.22M$50Mdetails · SEC filing

How the total is counted: the amount sold on each new offering, added together. Amendments are left out, because an amendment restates an offering already counted. A filing whose figures have not been read yet shows a dash and adds nothing.

Every figure here is read from Halia Therapeutics, Inc.'s own filings with the SEC. The people those filings name are on the team page.

Cite this page

Permanent URL: https://mentionfox.com/company/halia-therapeutics-inc
Last updated 2026-09-26
Primary record: SEC filing 1 · SEC filing 2 · SEC filing 3
Halia Therapeutics, Inc. funding history: 3 SEC filings, $15.71M raised. MentionFox, 2026-09-26. https://mentionfox.com/company/halia-therapeutics-inc